Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)

SHA:688553 Revenue

Sichuan Huiyu Pharmaceutical had revenue of 313.86M CNY in the quarter ending September 30, 2026, with 8.74% growth. This brings the company's total for the last twelve months to 1.12B, up 14.00% year-over-year. In the year 2025, Sichuan Huiyu Pharmaceutical had annual revenue of 998.14M, down -8.79%. That makes Sichuan Huiyu Pharmaceutical the 18,748th largest company in the world by revenue and 3,429th in China.

• Revenue (ttm): 1.12B
• Revenue Growth: +14.00%
• P/S Ratio: 5.96
• Revenue / Employee: 821.46K
• Employees: 1,446
• Market Cap: 6.69B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 782.05M 78.4%
• Overseas 216.09M 21.6%

Fiscal year ended Dec 31, 2025 See the full SHA:688553 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	998.14M	-96.24M	-8.79%
Dec 31, 2024	1.09B	167.31M	18.05%
Dec 31, 2023	927.08M	-566.19M	-37.92%
Dec 31, 2022	1.49B	-330.47M	-18.12%
Dec 31, 2021	1.82B	459.54M	33.69%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error